RXS — Pacific Radiance Income Statement
0.000.00%
Last trade - 00:00
- SG$51.06m
- SG$67.56m
- $31.41m
- 39
- 87
- 63
- 73
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 74.8 | 8.93 | 9.85 | 29.9 | 31.4 |
Cost of Revenue | |||||
Gross Profit | 15.2 | 0.731 | 0.145 | 13.8 | 12.5 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 131 | 12.2 | 8.7 | -309 | 15.3 |
Operating Profit | -56.7 | -3.23 | 1.15 | 338 | 16.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -82.3 | -6.17 | 1.43 | 336 | 15.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -83.4 | -6.22 | 1.36 | 336 | 14.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -84.7 | -58.6 | -44.2 | 331 | 14.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -84.7 | -58.6 | -44.2 | 331 | 14.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -6.82 | -0.169 | -0.048 | -0.317 | 0.02 |